Diet Dr. Pepper Crowned Best Zero-Calorie Soda in Expert’s Taste Test Rankings 
Mars or Bust: Elon Musk's SpaceX Seeks Adventurers for Dangerous Red Planet Mission 
China’s Budget Spending Falls as Land Sale Revenue Plummets, Raising Economic Concerns 
Keeper Password Manager Offers 50% Discount to Enhance Digital Security for All Users 
Puma Enters Web3 Gaming with UNKJD Soccer Collaboration, Aiming to Drive Blockchain Adoption 
Bitcoin Rumor Ignites: Michael Saylor of MicroStrategy Hints US Banks to Custody Bitcoin 
China Brings Europe's First AWD Electric Pickup—Meet Maxus eTerron 9 with 267-Mile Range 
Crypto Whale Nets $200K Profit After $3.2M PEPE, FLOKI, and WLD Dump Amid Market Shift 
Shiba Inu's Shytoshi Kusama Teases “Big Plans” After TOKEN2049 Conference Appearance 
ByteDance Denies Nvidia Chip Replacement Plans; No Intent to Develop Own Chips 
Shiba Inu's Shytoshi Kusama Teases Tron Partnership at Token2049, SHIB Army Ablaze 
McDonald’s Teams Up With Crocs Again for Exclusive Happy Meal Collectible Clips 
McDonald’s, Burger King, Starbucks, Dunkin’ and More: Must-Try Healthy Menu Options Before September Ends 
Bitcoin Expected to Hit $200K by 2025, Standard Chartered Cites Key Economic and Regulatory Shifts 
Shiba Inu Fees Jump 2,024%: Shibarium Gas Costs Rise with User Surge 
Checkers & Rally’s Partners with T-Pain to Launch New $5 BBQ-Inspired Meal Deal 
Reckitt Benckiser is considering the sale of its subsidiary, Mead Johnson Nutritionals, which is based in China. It was said that the British multinational consumer goods company is eyeing at least $2 billion for the deal.
Sources who have knowledge on the matter told Reuters that Reckitt Benckiser already hired the American financial services company, Morgan Stanley, to review its Mead Johnson infant formula unit in Greater China. The insiders were not names since the information shared is confidential.
The plans for the sale of Mead Johnson’s infant formula
Based on the report, Reckitt Benckiser could commence the sale process any time within the second quarter of this year. As soon as the bank receives feedback or recommendation from potential buyers, the sale will begin.
Then again, all the interested parties have been warned that Reckitt Benckiser has not made any definite decision yet, and business valuation could still change because of the negative effects of the COVID-19 pandemic. Moreover, in February, it was said that the company is exploring its other options on how to handle Mead Johnson’s infant formula unit.
In any case, Reckitt Benckiser acquired Mead Johnson in 2017 for $16.6 billion in 2017. The infant formula-maker gave the company billions from the sale of its leading milk brands that include Lactum, Enfapro, and Enfamil.
Why Mead Johnson is being sold
Reckitt Benckiser’s chief executive officer, Laxman Narasimhan, said that there is a big decline in sales in China which makes up 6 percent of the group sales. The reason for the dive is the closure of the Hong Kong border that is taking a long time to re-open due to coronavirus.
Also, the birth rate in one of the most populous countries in the world has gone down as well, so there is less infant to feed with the formula from Mead Johnson. Lastly, Chinese locals have been choosing to buy imported milk due to the 2008 milk contamination controversy scandal. In fact, it was noted that on China’s leading e-commerce platform, JD.Com, the top four best-selling brands of infant formula are all from foreign labels.
